Clasado has secured seven more self-substantiated food-health claims for its prebiotic galactooligosaccharide (GOS) ingredient, Bimuno GOS, with Food Standards Australia and New Zealand (FSANZ).
Centring around gut and immune health support in just 7 days, as well as its targeted benefits for elite athletes, the additions take the total to 29, solidifying Bimuno GOS as the standout choice for health and nutrition formulators in Australia and New Zealand.
The claims were submitted in collaboration with Pathway International (‘Pathway’), the exclusive distributor of Bimuno GOS to Australia and New Zealand.
The new range of claims, supported by the studies behind the prebiotic ingredient, are:
- Benefits gut health in 7 days.
- Supports/aids/helps/assists/promotes/stimulates/restores/improves digestive wellbeing in 7 days.
- Supports/maintains a healthy digestive system in 7 days.
- Supports gut health in elite athletes.
- Supports immune health in elite athletes.
- May reduce the incidence and severity of mild gastrointestinal symptoms experienced by elite athletes.
- May reduce the duration of minor upper respiratory symptoms by 2 days in elite athletes.
These claims, which can be featured on food products containing Bimuno GOS in Australia and New Zealand, are underpinned by the scientific studies and clinical trials behind Bimuno GOS, exemplifying Clasado's unwavering commitment to providing evidence-based solutions for modern health and nutrition products.
Lucie Nagy, General Counsel for Clasado Biosciences, said: "The addition of 7 new food-health relationship claims with FSANZ represents a significant step forward in our mission to offer the very best in gut health innovation, and a fantastic achievement for our team. Science and substantiated evidence are at the heart of everything we do, and that resonates with today’s consumer needs.
In collaboration with Clasado, the latest developments with FSANZ serve to further enhance the already outstanding value proposition of Bimuno GOS
- Wayne Coote, Founder & MD at Pathway International
Wayne Coote, Founder & MD at Pathway International said: “In collaboration with Clasado, the latest developments with FSANZ serve to further enhance the already outstanding value proposition of Bimuno GOS, particularly in the sports health field. We are enthusiastic about the array of possibilities that Bimuno GOS presents, especially given the escalating consumer demand for prebiotics around the world.”
"The rising recognition of the health advantages and remarkable stability of prebiotic fibres is driving their prominence in new product innovation, and we are delighted to supply Bimuno GOS to formulators across Australia and New Zealand that are seeking a scientifically backed functional core ingredient.”
As the global demand for gut health solutions intensifies, Clasado remains at the forefront. Bimuno GOS is poised to empower formulators across Australia and New Zealand, offering unmatched stability and versatility. The ingredient benefits from a low efficacious dose, beginning from just 1.37g per day.
